Gorgani, N. N., Kim, K. H. S., Free, W. L., Afkham, M., Henson, J. D., Shamanna, P., Ajdari, S. ., Kahn, C. R. ., Hirst, T. R. ., Barnett, A. H. ., & Paul, S. K. . (2022). OZ101, an oligofructose prebiotic, may prolong sulphonylurea efficcy in patients with type 2 diabetes: a pilot study: OZ101 and sulphonylurea-mediated glycaemic control. Journal of Current Medical Research and Opinion, 5(06), 1235–1251. https://doi.org/10.52845/CMRO/2022/5-6-2